CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Bariatric Embolization of Arteries with imaging visible Embolicsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04197336
NCT04197336N/ACompleted
CompareCT.gov

Bariatric Embolization of Arteries With Imaging Visible Embolics

Johns Hopkins University·interventional·Posted Dec 13, 2019·Updated Mar 17, 2025

In Brief

A clinical study evaluating Bariatric Embolization of Arteries with imaging visible Embolics for Obesity and 2 related conditions. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The BEATLES study is an investigator-initiated, prospective, double-blinded, randomized, sham-controlled study that will assess the impact of bariatric embolization on the systemic levels of obesity-related hormones and, as a consequence, on weight loss. The goal of this study is to help treat obesity combining a lifestyle program and a minimally invasive, angiographic (i.e., through blood vessels) approach.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Morbid Obesity, Weight Loss
CountriesUnited States
CollaboratorsBiocompatibles UK Ltd

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 13, 2019
Enrollment StartJan 10, 2020
Primary CompletionDec 14, 2023
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 6.6 years ago

Interventions

Bariatric Embolization of Arteries with imaging visible Embolicsdevice

bariatric embolization will be performed using tiny (100-200 μm), radiopaque (visible on X-ray) beads (referred to as BTG-001933) in order to suppress the body's signals for feeling hungry, which we predict will lead to weight loss.